Show simple item record

The Combination Of Venetoclax, Lenalidomide And Rituximab In Patients With Newly Diagnosed Mantle Cell Lymphoma Induces High Response Rates And Mrd Undetectability

dc.contributor.authorPhillips, T. J.
dc.contributor.authorBond, D.
dc.contributor.authorDevata, S.
dc.contributor.authorDanilov, A.
dc.contributor.authorHerrera, A.
dc.contributor.authorMaddocks, K.
dc.contributor.authorWilcox, R.
dc.contributor.authorKarimi, Y.
dc.contributor.authorCarty, S.
dc.contributor.authorKaminski, M.
dc.contributor.authorPopplewell, L.
dc.date.accessioned2021-07-01T20:12:34Z
dc.date.available2022-07-01 16:12:33en
dc.date.available2021-07-01T20:12:34Z
dc.date.issued2021-06
dc.identifier.citationPhillips, T. J.; Bond, D.; Devata, S.; Danilov, A.; Herrera, A.; Maddocks, K.; Wilcox, R.; Karimi, Y.; Carty, S.; Kaminski, M.; Popplewell, L. (2021). "The Combination Of Venetoclax, Lenalidomide And Rituximab In Patients With Newly Diagnosed Mantle Cell Lymphoma Induces High Response Rates And Mrd Undetectability." Hematological Oncology 39: n/a-n/a.
dc.identifier.issn0278-0232
dc.identifier.issn1099-1069
dc.identifier.urihttps://hdl.handle.net/2027.42/168327
dc.publisherWiley Periodicals, Inc.
dc.subject.otherAggressive B‐cell non‐Hodgkin lymphoma
dc.subject.otherCombination Therapies
dc.subject.otherOngoing Trials
dc.titleThe Combination Of Venetoclax, Lenalidomide And Rituximab In Patients With Newly Diagnosed Mantle Cell Lymphoma Induces High Response Rates And Mrd Undetectability
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbsecondlevelNeurosciences
dc.subject.hlbsecondlevelObstetrics and Gynecology
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelOphthalmology
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168327/1/hon61_2879.pdf
dc.identifier.doi10.1002/hon.61_2879
dc.identifier.sourceHematological Oncology
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.